Boston Scientific TheraSphere improves survival in mCRC patients
The addition of TheraSphere treatment to second-line chemotherapy improved progression-free survival (PFS) and hepatic PFS.
Treatments
FDA approves Abbott’s transcatheter aortic valve replacement system
The system is indicated for severe aortic stenosis patients with high or extreme risk for...
Miach Orthopaedics begins treatment in BEAR Implant post-market study
The single-arm, multi-centre cohort study, which will enrol 250 patients, has a follow-up of ten...
Tactile Medical acquires International Biophysics’ AffloVest business
AffloVest complements Tactile Medical’s focus on at-home treatments for patients with underserved chronic diseases.
Glaukos submits application to US FDA for iStent infinite device
iStent infinite has three heparin-coated titanium stents preloaded into an auto-injection system.
Philips to begin replacing DreamStation respiratory devices in US
The company secured US FDA approval to repair the affected DreamStation devices and is discussing a mitigation plan further.
Medical tourism market set to recover from the Covid-19 pandemic
With the resumption of travel, medical tourism is set to see growth by the end of 2022 at pre-pandemic rates as demand is being restored.
Fresenius Medical Care makes additional investment in Humacyte
With the latest investment, Fresenius Medical Care plans to grow its position in the combined entity of Humacyte and a SPAC.
Abbott’s CardioMEMS system lowers mortality in heart failure patients
Data adjusted for the Covid-19 impact showed that the device led to a significant decrease in heart failure hospitalisations.
Catalyst OrthoScience unveils imaging software for preoperative planning
Archer 3D Targeting uses 2D images to provide surgeons with a better understanding of patient pathology.
Telix and Lightpoint to integrate technologies for radioguided surgery
The companies will assess the use of a SPECT imaging agent along with SENSEI for cancer detection during surgery.
